MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET Net Income
Bottom-line profit after all expenses, interest, and taxes.
MetLife, Inc.NYSE: MET
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income growth accelerates
Q2 FY2026 net income of $736M rose 1.0% year over year, ahead of the -15.4% change in trailing-twelve-month net income. Sequentially, it fell 37.9% from the prior quarter. Over 3 fiscal years it compounded at -13.8% a year.
Context
- Net income amounted to 4.4% of revenue in FY2025, down 1.9 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 6 analysts of $6.57B (+94.4%) for the fiscal year ending Dec 2026, a step up from the -23.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $736M-37.9% QoQ
- Last fiscal yearDec 2025
- $3.38B-23.7% YoY
- LTMJun 2026
- $3.63B-15.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +1.0% | +98.1% | +97.1 pp |
| 1 year | -23.7% | +94.4% | +118.0 pp |
| 3-year CAGR | -13.8% | +34.0% | +47.8 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- 3.38B USD
- Year-over-year change
- -23.7%
- 4-year CAGR
- -16.2%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3.38B | -23.7% |
| FY2024 | 2024-12-31 | 4.43B | +180.5% |
| FY2023 | 2023-12-31 | 1.58B | -70.1% |
| FY2022 | 2022-12-31 | 5.28B | -22.9% |
| FY2021 | 2021-12-31 | 6.86B | — |
Net Income vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -15.4% is the 9th highest of 11, against a peer median of +10.9%.
- Net income amounts to 4.6% of revenue for MET, versus a peer median of 12.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CA$6.73B CAD | +11.2% | — | 11.6% | |
| LTM Jun 2026 | $4.86B USD | +99.5% | -6.2% | 26.9% | |
| LTM Jun 2026 | $3.84B USD | +135.6% | — | 5.9% | |
| LTM Jun 2026 | $3.63B USD | -15.4% | -13.8% | 4.6% | |
| LTM Jun 2026 | $2.36B USD | +107.7% | -4.7% | 12.2% | |
| LTM Sep 2026 | $1.19B USD | +3.0% | +9.1% | 18.9% | |
| LTM Sep 2026 | $798.55M USD | +10.7% | +16.8% | 23.1% | |
| LTM Jun 2026 | $702.7M USD | -53.7% | -19.3% | 5.3% | |
| LTM Sep 2026 | $682M USD | -29.5% | -51.9% | 12.6% | |
| LTM Jun 2026 | $608M USD | +14.1% | +8.6% | 16.1% | |
| LTM Jun 2026 | $279.6M USD | -0.5% | -28.6% | 6.0% | |
| Peer median (excluding MET) | — | +10.9% | -5.4% | 12.4% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.